MX2020010199A - Polipeptidos antigenicos del virus sincitial respiratorio. - Google Patents
Polipeptidos antigenicos del virus sincitial respiratorio.Info
- Publication number
- MX2020010199A MX2020010199A MX2020010199A MX2020010199A MX2020010199A MX 2020010199 A MX2020010199 A MX 2020010199A MX 2020010199 A MX2020010199 A MX 2020010199A MX 2020010199 A MX2020010199 A MX 2020010199A MX 2020010199 A MX2020010199 A MX 2020010199A
- Authority
- MX
- Mexico
- Prior art keywords
- respiratory syncytial
- syncytial virus
- antigenic
- virus polypeptides
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Esta divulgación versa sobre polipéptidos antigénicos del virus sincitial respiratorio (VSR) para su uso en la obtención de anticuerpos contra el VSR. También se divulgan polipéptidos antigénicos que comprenden un polipéptido del VSR y una proteína ferritina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862652199P | 2018-04-03 | 2018-04-03 | |
PCT/US2019/025387 WO2019195291A1 (en) | 2018-04-03 | 2019-04-02 | Antigenic respiratory syncytial virus polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020010199A true MX2020010199A (es) | 2021-01-08 |
Family
ID=66182672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020010199A MX2020010199A (es) | 2018-04-03 | 2019-04-02 | Polipeptidos antigenicos del virus sincitial respiratorio. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210017237A1 (es) |
EP (1) | EP3773704A1 (es) |
JP (1) | JP2021519597A (es) |
KR (1) | KR20210018206A (es) |
CN (1) | CN112512567A (es) |
AU (1) | AU2019247034A1 (es) |
BR (1) | BR112020019938A2 (es) |
CA (1) | CA3095175A1 (es) |
MX (1) | MX2020010199A (es) |
WO (1) | WO2019195291A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019195316A1 (en) | 2018-04-03 | 2019-10-10 | Sanofi | Ferritin proteins |
EP3773708A2 (en) | 2018-04-03 | 2021-02-17 | Sanofi | Antigenic epstein barr virus polypeptides |
WO2023079507A1 (en) | 2021-11-05 | 2023-05-11 | Sanofi | Respiratory syncytial virus rna vaccine |
WO2023201222A1 (en) * | 2022-04-11 | 2023-10-19 | Vanderbilt University | Ferritin nanoparticles and methods of use thereof |
WO2024041773A1 (en) * | 2022-08-22 | 2024-02-29 | Glaxosmithkline Biologicals Sa | Rsv-f proteins |
CN117586359A (zh) * | 2024-01-19 | 2024-02-23 | 北京安百胜生物科技有限公司 | 一种具有免疫原性的呼吸道合胞病毒(rsv)多肽 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5585250A (en) * | 1993-08-20 | 1996-12-17 | The United States Of America As Represented By The Department Of Health & Human Services | Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies |
US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6194388B1 (en) | 1994-07-15 | 2001-02-27 | The University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
WO1998037919A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
WO1998052581A1 (en) | 1997-05-20 | 1998-11-26 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
US6218371B1 (en) | 1998-04-03 | 2001-04-17 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
WO2001075436A1 (en) | 2000-04-03 | 2001-10-11 | Board Of Trustees Of The Leland Stanford Junior University | A method for protein structure alignment |
US7774185B2 (en) | 2004-09-14 | 2010-08-10 | International Business Machines Corporation | Protein structure alignment using cellular automata |
EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
IN2014CN02114A (es) * | 2011-09-20 | 2015-05-29 | Sinai School Medicine | |
JP6703475B2 (ja) * | 2013-03-13 | 2020-06-03 | アメリカ合衆国 | 融合前rsvfタンパク質およびそれらの使用 |
PT3148578T (pt) * | 2014-05-27 | 2022-08-23 | Us Health | Trímeros estabilizados da região do caule da hemaglutinina do vírus da gripe e suas utilizações |
US9703095B2 (en) | 2015-01-05 | 2017-07-11 | Edward Pakhchyan | Light modulator for MEMS display |
KR20170140180A (ko) * | 2015-02-24 | 2017-12-20 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 중동 호흡기 증후군 코로나 바이러스 면역원, 항체 및 그 용도 |
WO2017172890A1 (en) * | 2016-03-29 | 2017-10-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Substitutions-modified prefusion rsv f proteins and their use |
MX2018015787A (es) | 2016-06-17 | 2019-04-22 | Merial Inc | Formulaciones inmunogenicas novedosas que comprenden adyuvantes de polimero de acido poliacrilico lineal o ramificado. |
-
2019
- 2019-04-02 KR KR1020207031417A patent/KR20210018206A/ko unknown
- 2019-04-02 BR BR112020019938-9A patent/BR112020019938A2/pt unknown
- 2019-04-02 WO PCT/US2019/025387 patent/WO2019195291A1/en active Application Filing
- 2019-04-02 AU AU2019247034A patent/AU2019247034A1/en active Pending
- 2019-04-02 EP EP19718031.8A patent/EP3773704A1/en active Pending
- 2019-04-02 JP JP2020554448A patent/JP2021519597A/ja active Pending
- 2019-04-02 MX MX2020010199A patent/MX2020010199A/es unknown
- 2019-04-02 CA CA3095175A patent/CA3095175A1/en active Pending
- 2019-04-02 CN CN201980036093.4A patent/CN112512567A/zh active Pending
-
2020
- 2020-10-01 US US17/061,065 patent/US20210017237A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2019195291A1 (en) | 2019-10-10 |
JP2021519597A (ja) | 2021-08-12 |
AU2019247034A1 (en) | 2020-10-22 |
KR20210018206A (ko) | 2021-02-17 |
EP3773704A1 (en) | 2021-02-17 |
CA3095175A1 (en) | 2019-10-10 |
BR112020019938A2 (pt) | 2021-01-26 |
US20210017237A1 (en) | 2021-01-21 |
RU2020135568A (ru) | 2022-05-06 |
CN112512567A (zh) | 2021-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020010199A (es) | Polipeptidos antigenicos del virus sincitial respiratorio. | |
PH12018501882A1 (en) | Binding proteins and methods of use thereof | |
HK1257518A1 (zh) | 針對人白介素-2的免疫刺激性人源化單克隆抗體及其融合蛋白 | |
WO2019195314A3 (en) | Antigenic epstein barr virus polypeptides | |
EP4223784A3 (en) | Compositions and methods for modulating t-cell mediated immune response | |
MY172997A (en) | Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides | |
MX2018015755A (es) | Proteinas de hemaglutinina de virus de influenza y usos de las mismas. | |
EA202190906A1 (ru) | Рекомбинантное получение препаратов пептидов коллагена и их применение | |
WO2018187356A3 (en) | Protein antigens and uses thereof | |
MX2019006349A (es) | Proteinas recombinantes rsv f de prefusion nuevas y usos de las mismas. | |
MX2021001129A (es) | Metodo de purificacion de antigenos. | |
EP3626747A4 (en) | NEW RECOMBINANT BIFUNCTIONAL FUSION PROTEIN, PROCESS OF PREPARATION AND USE | |
WO2013150309A8 (en) | Clostridium difficile antigens | |
MX2020009116A (es) | Proteinas triespecificas de union a antigenos. | |
WO2015112558A3 (en) | Peptides, devices, and methods for the detection of anaplasma antibodies | |
MX2019002178A (es) | Peptidos de fusion con antigenos enlazados a fragmentos cortos de cadena invariante (cd74). | |
ZA202101260B (en) | Long-acting recombinant glp1-fc-cd47 protein, preparation method and use thereof | |
EP4054343C0 (en) | EXTENDED WHEY PROTEIN HYDROLYSATE WITH TOLERogenic PEPTIDES | |
PH12019502449A1 (en) | Anti-jagged1 antigen binding proteins | |
IL281203A (en) | Pneumococcal fusion protein vaccines | |
EP3634145A4 (en) | POLYPEPTIDE, USE AND PROCESS FOR HYDROLYSIS OF PROTEIN | |
EP3615060A4 (en) | HSV ANTIGENIC PEPTIDES AND HSV PROTEIN VACCINES | |
MX2018003445A (es) | Expresion de proteinas que contienen fc. | |
EP3741774A4 (en) | N-TERMINAL FUSION PARTNER FOR THE MANUFACTURING OF A RECOMBINANT POLYPEPTID AND PROCESS FOR THE MANUFACTURING OF A RECOMBINANT POLYPEPTID USING THESE | |
MX2015011931A (es) | Expresion mejorada de proteinas de picornavirus. |